Brief: Promore Pharma Jan-March Operating Loss Was SEK 7.9 mln
May 16 (Reuters) - Promore Pharma AB PROMO.ST :
* JAN-MARCH NET SALES AMOUNTED TO MSEK 0.1 (0) MSEK
* JAN-MARCH OPERATING LOSS FOR PERIOD WAS 7.9 (LOSS 3.2) MSEK
* JAN-MARCH NET LOSS WAS 7.9 MSEK (LOSS 3.3) MSEK, CORRESPONDING TO A LOSS PER SHARE OF SEK
0.39
(LOSS 0.24)
Source text for Eikon: ID:nWkr8JGtxp
Further company coverage: PROMO.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality